Cargando…
Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism
The circulating metabolome provides unique insights into multiple sclerosis (MS) pathophysiology, but existing studies are relatively small or characterized limited metabolites. We test for differences in the metabolome between people with MS (PwMS; n = 637 samples) and healthy controls (HC; n = 317...
Autores principales: | Fitzgerald, Kathryn C., Smith, Matthew D., Kim, Sol, Sotirchos, Elias S., Kornberg, Michael D., Douglas, Morgan, Nourbakhsh, Bardia, Graves, Jennifer, Rattan, Ramandeep, Poisson, Laila, Cerghet, Mirela, Mowry, Ellen M., Waubant, Emmanuelle, Giri, Shailendra, Calabresi, Peter A., Bhargava, Pavan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561319/ https://www.ncbi.nlm.nih.gov/pubmed/34755135 http://dx.doi.org/10.1016/j.xcrm.2021.100424 |
Ejemplares similares
-
Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course
por: Nourbakhsh, Bardia, et al.
Publicado: (2018) -
Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes
por: Bhargava, Pavan, et al.
Publicado: (2018) -
Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo
por: Udumula, Mary P., et al.
Publicado: (2022) -
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target
por: Zahoor, Insha, et al.
Publicado: (2022) -
Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis
por: Fitzgerald, Kathryn C., et al.
Publicado: (2022)